We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GLAXOSMITHKLINE REPORTS POSITIVE DRUG TRIAL RESULTS
GLAXOSMITHKLINE REPORTS POSITIVE DRUG TRIAL RESULTS
June 19, 2006
UK-based pharmaceutical major GlaxoSmithKline Plc Monday reported encouraging results of the phase III clinical trials of its experimental drug, eltrombopag. The drug was researched in collaboration with Ligand Pharmaceuticals. Newratings
